Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07569250 · ClinicalTrials.gov registry record · NA
Increasing CRC Screening in Community Health Centers Through Mobile Messaging Optimization
A NA study, sponsored by University of Colorado, Denver.
- Not yet
- Registry status
- NA
- Development phase
- 7,220
- Enrollment target
NCT07569250: Clinical Trial NA study, sponsored by University of Colorado, Denver.
NCT07569250 is a NA study that has not yet begun recruiting, run by University of Colorado, Denver. The registered enrollment target is 7,220 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (415% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07569250, a NA study, has not yet begun recruiting, sponsored by University of Colorado, Denver.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 7,220 participants
- Enrollment target
Study Summary
The goal of this interventional study is to create and test a comprehensive and low burden text message program within existing Community Health Centers (CHC) electronic records system to encourage patients to complete at home colorectal cancer (CRC) screening and to make sure they get follow-up care if their results are abnormal. First, the investigators will learn from clinic staff and patients what their needs and preferences are in terms of use of technology. This information will be used to design the text messages program. * Clinic patients will participate in focus groups * Clinic staff will participate in interviews Second, the investigators will test a series of different message versions in two batches (experiments): * Clinic patients with orders for an at-home colorectal cancer screening kit will receive the different message versions. * In the first batch, the messages that get the most engagement from patients will be selected to be used in the second experiment. * In the second batch, the investigators will test which messages lead to the most colorectal cancer screening completion. * This will be rolled-out within the clinics existing electronic record system. The study team will not receive any information that will identify individual patients. Lastly, the investigators will check again with clinic staff to learn how the program performed, and what would be needed to continue using the text message program in the long run. -Clinic staff will participate in interviews and surveys.
Primary Outcome
Proportion of message recipients who interact with CRC screening reminder messages by reply
Interventions
- BEHAVIORAL Personalized Text Message
- BEHAVIORAL Screening Concerns Text Message
- BEHAVIORAL Message Framing Text Message
- BEHAVIORAL Autonomy Support Outreach
- BEHAVIORAL Impediments Support Outreach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,220 participants |
| Start Date | 2026-12 |
| Est. Completion | 2032-01 |
| Phase | NA |
What is known before NCT07569250 opens enrollment
NCT07569250 is an interventional study that assigns participants to a tested intervention. Its 7,220 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (415% higher).
The record links to 0 conditions, and to 5 interventions - of which Personalized Text Message is the first listed.
NCT07569250 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07569250 about?
NCT07569250 is a clinical study titled "Increasing CRC Screening in Community Health Centers Through Mobile Messaging Optimization". The goal of this interventional study is to create and test a comprehensive and low burden text message program within existing Community Health Centers (CHC) electronic records system to encourage patients to complete at home colorectal cancer (CRC) screening and to make sure they get follow-up car...
What is the current status of trial NCT07569250?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 7,220 participants. The study started on 2026-12. Estimated completion is 2032-01.
What interventions are being tested in trial NCT07569250?
The interventions under investigation include: Personalized Text Message (BEHAVIORAL), Screening Concerns Text Message (BEHAVIORAL), Message Framing Text Message (BEHAVIORAL), Autonomy Support Outreach (BEHAVIORAL), Impediments Support Outreach (BEHAVIORAL).
Who is sponsoring clinical trial NCT07569250?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07569250's enrollment target sits among peer trials
7,220 20th of 2000 higher than 1,981 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05049837 · 7,200 participants
PROSPECT - Profiling of Resistance Patterns & Oncogenic Signaling Pathways in Evaluation of Cancers of the Thorax and Therapeutic Target Identification
- NCT06714929 · 7,200 participants · NA
Advancing Water Security: A Community Participatory School-Based Hydration Intervention
- NCT06843720 · 7,100 participants · NA
Expanding Access to Cervical Cancer Screening Through Primary HR-HPV Testing and Self-sampling: a Multicomponent Intervention for Safety Net Health Systems
- NCT02915198 · 7,410 participants · Phase 4
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia